Hyperfine, Inc. (HYPR)
0.9307
-0.01
(-1.00%)
USD |
NASDAQ |
Oct 09, 16:00
0.93
0.00 (0.00%)
After-Hours: 20:00
Hyperfine Cash from Operations (Quarterly) : -7.268M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -7.268M |
| March 31, 2026 | -9.008M |
| December 31, 2025 | -5.207M |
| September 30, 2025 | -5.582M |
| June 30, 2025 | -7.91M |
| March 31, 2025 | -9.249M |
| December 31, 2024 | -8.357M |
| September 30, 2024 | -8.517M |
| June 30, 2024 | -9.383M |
| March 31, 2024 | -12.51M |
| December 31, 2023 | -9.938M |
| Date | Value |
|---|---|
| September 30, 2023 | -8.721M |
| June 30, 2023 | -9.659M |
| March 31, 2023 | -13.49M |
| December 31, 2022 | -15.34M |
| September 30, 2022 | -12.79M |
| June 30, 2022 | -16.91M |
| March 31, 2022 | -27.29M |
| December 31, 2021 | -18.14M |
| September 30, 2021 | -9.943M |
| June 30, 2021 | -11.62M |
| March 31, 2021 | -7.486M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Abbott Laboratories | 2.488B |
| AngioDynamics, Inc. | -15.33M |
| Alphatec Holdings, Inc. | 20.51M |
| AtriCure, Inc. | 22.19M |
| Baxter International, Inc. | 285.00M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.03M |
| Cash from Financing (Quarterly) | 10.78M |
| Free Cash Flow | -27.53M |
| Free Cash Flow Per Share (Quarterly) | -0.0731 |
| Free Cash Flow to Equity (Quarterly) | -7.342M |
| Free Cash Flow to Firm (Quarterly) | -6.765M |
| Free Cash Flow Yield | -31.92% |